FINWIRES · TerminalLIVE
FINWIRES

Update: Rio Tinto Group Begins Commissioning Nearly $2 Billion AP60 Smelter Expansion in Canada

By

(Updates to add stock movement in the last paragraph)

Rio Tinto Group (ASX:RIO) started commissioning its $1.5 billion AP60 aluminum smelter expansion at Complexe Arvida in Quebec, with start-up work having commenced in March and full 96-pot operations targeted for completion by the end of year, the company said on May 29 after hours.

The project will increase AP60's annual aluminum capacity by about 160,000 tonnes to around 220,000 tonnes while replacing output from older Arvida potrooms scheduled for closure in June.

The expansion is expected to support about 100 permanent jobs, generate over 1,500 construction jobs, and contribute more than $1 billion in economic benefits to Quebec.

The company's shares rose past 1% in recent Monday trade.

Related Articles

Asia

Syrah Resources Resolves Offtake Agreement Issues With Tesla; Shares Jump 26%

Syrah Resources (ASX:SYR) said Tesla no longer plans to terminate an offtake agreement with the company after Syrah showed that it is producing conforming active anode material samples, according to a Monday filing with the Australian bourse.Tesla previously claimed that Syrah defaulted on an obligation under the agreement to provide conforming natural graphite active anode material samples from a facility in Louisiana, US.Syrah said it has now "made sufficient progress to cure the alleged default" and is progressing through later stages of qualification testing approvals with Tesla.Shares of Syrah Resources jumped more than 26% in recent Monday trade.

$ASX:SYR
Asia

Lupin Gets US FDA's Nod for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablet

Indian pharmaceutical company Lupin (NSE:LUPIN, BOM:500257) has received approval from the U.S. Food and Drug Administration for its Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets in the strengths of 1.479 grams, 0.225 grams, and 0.188 grams.The tablets are bioequivalent to Azurity Pharmaceuticals' reference listed drug, Sutab Tablets, which are used to cleanse the colon as a preparation for colonoscopy in adults.Lupin said it is eligible for 180-day generic drug exclusivity as it was the first to file for the product, which will be manufactured at Lupin's Nagpur facility in India.IQVIA data estimates annual sales of $132.8 million for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets in the U.S. in the 12 months ended March.

$BOM:500257$NSE:LUPIN
Asia

IperionX Titanium Fasteners Meet or Exceed SAE Grade 8 Steel in US Army-Backed Testing

IperionX (ASX:IPX) said independent testing by the US Army Combat CapabilitiesDevelopment Command Ground Vehicle Systems Center and Westmoreland Mechanical Testing & Research found its Ti-6Al-4V fasteners can meet or exceed SAE Grade 8 steel performance in torque-to-failure, torque-tension, and tensile strength tests, according to a Monday Australian bourse filing.Army testing showed that larger fasteners exceeded the yield torque of comparable Grade 8 steel, while smaller fasteners performed at or above steel levels, with some not yielding at the initial test thresholds, per the filing.Independent tensile testing measured yield strengths of 135 to 137 kilopounds per square inch (ksi) and ultimate tensile strengths of 149 to 152 ksi, meeting or exceeding key aerospace and high-strength steel standards, the filing said.The results highlight scalable, lower-cost titanium fasteners for defense and industrial use, reinforcing the company's role in developing a domestic US titanium supply chain via its powder-to-product technology, the filing added.The company's shares were up over 1% in recent Monday trade.

$ASX:IPX